Publication Date
In 2025 | 0 |
Since 2024 | 4 |
Descriptor
Integrity | 4 |
Medical Research | 4 |
Ethics | 3 |
Randomized Controlled Trials | 3 |
COVID-19 | 2 |
Foreign Countries | 2 |
Governance | 2 |
Pandemics | 2 |
Research Design | 2 |
Research Methodology | 2 |
Research Problems | 2 |
More ▼ |
Author
Angela C. Webster | 1 |
Angie Barba | 1 |
Anna Lene Seidler | 1 |
Ben W. Mol | 1 |
Carl Lombard | 1 |
Emma Law | 1 |
Fei Yan | 1 |
Fengyu Liu | 1 |
Gonasagrie Nair | 1 |
Isabel Smith | 1 |
James X. Sotiropoulos | 1 |
More ▼ |
Publication Type
Journal Articles | 4 |
Reports - Research | 3 |
Information Analyses | 1 |
Education Level
Audience
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Kylie E. Hunter; Mason Aberoumand; Sol Libesman; James X. Sotiropoulos; Jonathan G. Williams; Wentao Li; Jannik Aagerup; Ben W. Mol; Rui Wang; Angie Barba; Nipun Shrestha; Angela C. Webster; Anna Lene Seidler – Research Synthesis Methods, 2024
Increasing integrity concerns in medical research have prompted the development of tools to detect untrustworthy studies. Existing tools primarily assess published aggregate data (AD), though scrutiny of individual participant data (IPD) is often required to detect trustworthiness issues. Thus, we developed the IPD Integrity Tool for detecting…
Descriptors: Integrity, Randomized Controlled Trials, Data Use, Individual Characteristics
Wei Zhu; Fei Yan; Jianfeng Zhu; Linzi Zhu; Fengyu Liu – Research Ethics, 2024
This paper describes a scoping review of China's academic resource databases, relevant official websites, news reports and public accounts spanning a period from the end of 2019 to the end of 2022, to investigate the challenges in scientific integrity and ethical soundness of research conducted during and immediately after the COVID-19 pandemic in…
Descriptors: Foreign Countries, Ethics, Integrity, Research Methodology
Tiwonge K. Mtande; Carl Lombard; Gonasagrie Nair; Stuart Rennie – Research Ethics, 2024
Although the use of the cluster randomized trial (CRT) design to evaluate vaccines, public health interventions or health systems is increasing, the ethical issues posed by the design are not adequately addressed, especially in low- and middle-income country settings (LMICs). To help reveal ethical challenges, qualitative interviews were conducted…
Descriptors: Stakeholders, Ethics, Randomized Controlled Trials, Medical Research
Emma Law; Isabel Smith – Research Ethics, 2024
During the COVID-19 pandemic, the race to find an effective vaccine or treatment saw an 'extraordinary number' of clinical trials being conducted. While there were some key success stories, not all trials produced results that informed patient care. There was a significant amount of waste in clinical research during the pandemic which is said to…
Descriptors: Ethics, Research Methodology, Integrity, COVID-19